Bradley L. Campbell, President and CEO at AMICUS THERAPEUTICS, INC. (FOLD), sold 29,174 shares at $10.04 ($293K) on 2025-11-24, disclosed to the SEC on 2025-11-26.
Scheduled sale ($293k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.04 | 14,587 | $146K | 50.0% |
| 2 | $10.04 | 14,587 | $146K | 50.0% |
| Total | $10.04 avg | 29,174 | $293K | 100% |
| Filing → |
| FOLD | SELL | 2025-12-17 | $1.7M | — | Filing → |
| FOLD | SELL | 2025-12-03 | $292K | — | Filing → |
| FOLD | SELL | 2025-02-21 | $4K | — | Filing → |